We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 70 days · 70 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 70 days • 1 price levels
Price Analysis
Most common price: £520 (70 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 70 days
Description
This study covers the latent demand outlook for peripheral neuropathy treatments across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and city, latent demand estimates are created for peripheral neuropathy treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of peripheral neuropathy treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Assertio Therapeutics, Baxter International, Biogen, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, and Sanofi. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BLR6W56G
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
99% match
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in India
£515.00
21 Aug 2026
99% match
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in China
£495.00
20 Aug 2026
99% match
The 2026-2031 World Outlook for Peripheral Neuropathy Treatments
£885.00
20 Aug 2026
98% match
The 2023-2028 Outlook for Peripheral Neuritis Treatments in India
£515.00
21 Aug 2026
98% match
The 2026-2031 World Outlook for Peripheral Neuritis Treatments
£885.00
22 Aug 2026
97% match
The 2023-2028 Outlook for Diabetic Neuropathy in the United States
£520.00
20 Aug 2026
97% match
The 2023-2028 Outlook for Peripheral Neuritis Treatments in China
£495.00
13 Aug 2026
97% match
Peripheral Neuropathy - Causes, Symptoms, and Treatment Options
IntechOpen
£118.98
19 Sep 2026
97% match
Peripheral Neuropathy - Advances in Diagnostic and Therapeutic Approaches
IntechOpen
£119.00
19 Sep 2026
97% match
Peripheral Neuropathies, An Issue of Neurologic Clinics (Volume 43-4) (The Clinics: Internal Medicine, Volume 43-4)
Elsevier
£72.48
19 Sep 2026
97% match
The 2023-2028 Outlook for Peripheral Neuritis Treatments for US Zip Codes
£490.00
16 Aug 2026
97% match
Peripheral Neuropathy
IntechOpen
£119.00
24 Sep 2026
97% match
The 2023-2028 Outlook for Diabetic Neuropathy in India
£515.00
19 Aug 2026
97% match
Peripheral Neuropathy and Neuropathic Pain
Hayle Medical
£75.67
25 Sep 2026
97% match
The 2023-2028 Outlook for Nerve Repair and Regeneration in India
£515.00
25 Aug 2026
97% match
The 2023 Report on Peripheral Nerve Stimulators: World Market Segmentation by City
£795.00
11 Aug 2026
97% match
The 2026-2031 World Outlook for Peripheral Nerve Stimulators
£885.00
22 Aug 2026
96% match
Neuropathies périphériques. Volume 2 : Etiologies: Volume 2
DOIN EDITEURS
£67.88
23 Oct 2026
96% match
The 2021-2026 World Outlook for Nerve Repair and Regeneration
£795.00
25 Aug 2026
96% match
The 2025-2030 World Outlook for Diabetic Neuropathy
Price unavailable
96% match
The 2023-2028 World Outlook for Diabetic Neuropathy
Price unavailable
96% match
The 2023-2028 Outlook for Diabetic Neuropathy in China
£495.00
19 Aug 2026
96% match
The 2023-2028 Outlook for Diabetic Neuropathy in Japan
£495.00
11 Aug 2026
96% match
Neuropathies périphériques (Volume 1): Moyens d'explorations, évaluations et classifications
DOIN EDITEURS
£63.88
30 Aug 2026